NEW DELHI, Aug 25 - The Centre said on Tuesday that India and Russia are in communication regarding the Sputnik V vaccine. While some initial information has been shared, detailed information is being awaited by India.
Sputnik V, an adenovirus vector-based vaccine, was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology along with Russian Direct Investment Fund, and was registered on August 11. Talks are under way between India and Russia for collaboration on the vaccine.
Addressing the media, Union Health Ministry Secretary Rajesh Bhushan said, �As far as Sputnik V vaccine is concerned, India and Russia are in communication, some initial information has been shared and some detailed information is awaited.�
The remarks hold importance as last week, the CEO of the Russian Direct Investment Fund, Kirill Dmitriev, had said that Russia is looking for a partnership with India to produce the COVID-19 vaccine. � IANS
